Case Report
Scleromyxedema, a therapeutic dilemma
Julio Cesar Salas-Alanis, Brayant Martinez-Jaramillo, Minerva Gomez-Flores, Jorge Ocampo-Candiani
Published:
DOI:
10.4103/0019-5154.152600
License:
Copyright: © Indian Journal of Dermatology2015This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.